ExLibris header image
SFX Logo
Title: Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Chang, Yong yr:2013


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Grasberger, B.L. L. "Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells." Journal of medicinal chemistry 48.4 (2005): 909-912. Link to Full Text for this item Link to SFX for this item
2. Wachter, F. "Mechanistic validation of a clinical lead stapled peptide that reactivates p53 by dual HDM2 and HDMX targeting." Oncogene 36.15 (2016): 2184-2190. Link to Full Text for this item Link to SFX for this item
3. Grigoryev, Y. "Stapled peptide to enter human testing, but affinity questions remain." Nature medicine 19.2 (2013): 120-120. Link to SFX for this item
4. Shiheido, H. "mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction." PLoS ONE 6.3 (2011). Link to Full Text for this item Link to SFX for this item
5. Bernal, F. "A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53." Cancer cell 18.5 (2010): 411-422. Link to SFX for this item
6. Li, C. "Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53–MDM2 interaction." Bioorganic & medicinal chemistry 21.14 (2013): 4045-4050. Link to SFX for this item
7. Kelleher, BrianD W. "Complexity Generation in Fungal Peptidyl Alkaloid Biosynthesis: Oxidation of Fumiquinazoline A to the Heptacyclic Hemiaminal Fumiquinazoline C by the Flavoenzyme Af12070 from Aspergillus fumigatus." Biochemistry 50.40 (2011): 8756-8769. Link to Full Text for this item Link to SFX for this item
8. Fasan, R. "Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction." Chembiochem 7.3 (2006): 515-526. Link to Full Text for this item Link to SFX for this item
9. Koblish, Holly K K. "Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo." Molecular cancer therapeutics 5.1: 160-169. Link to SFX for this item
10. Vassilev, Lyubomir T. "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2." Science 303.5659 (2004): 844-848. Link to SFX for this item
11. Gangurde, K.-H. S. "Stapled  -helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy." Proceedings of the National Academy of Sciences of the United States of America 110.36 (2013). Link to Full Text for this item Link to SFX for this item
12. Bista, M. "Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction." Structure 21.12 (2013): 2143-51. Link to SFX for this item
13. Streeck, H. "Harnessing CD4(+) T cell responses in HIV vaccine development." Nature medicine 19.2 (2013): 143-149. Link to SFX for this item
14. Popowicz, Grzegorz M. "The Structure-Based Design of Mdm2/Mdmx-p53 Inhibitors Gets Serious." Angewandte Chemie (International ed. in English) 50.12 (2011): 2680-2688. Link to Full Text for this item Link to SFX for this item
15. Kim, Young-Woo W. "Introduction of all-hydrocarbon i,i+3 staples into alpha-helices via ring-closing olefin metathesis." Organic letters 12.13 (2010): 3046-3049. Link to Full Text for this item Link to SFX for this item
16. Phillips, A. "HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity." Journal of biological chemistry 285.38 (2010): 29111-29127. Link to Full Text for this item Link to SFX for this item
17. Giglio, S. "Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity." Oncogene 29.44 (2010): 5935-5945. Link to Full Text for this item Link to SFX for this item
18. Ho, G H H. "Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma." Breast cancer research and treatment 65.3 (2001): 225-32. Link to Full Text for this item Link to SFX for this item
19. Baunbaek, D. "Anticancer Alkaloid Lamellarins Inhibit Protein Kinases." Marine drugs 6.4 (2008): 514-527. Link to Full Text for this item Link to SFX for this item
20. Chae, S. "Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery." Bioconjugate chemistry 19.1 (2008): 334-341. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.